Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Stock-Based Compensation
$0.00
Quarterly · Period ending: · USD
BIO Stock-Based Compensation
Latest reported$0.00period ending
Latest reported$0.00period ending
BIO Quarterly Stock-Based Comp ($0.00 → $0.00)
Quarterly stock-based compensation
High-resolution chart · PNG
BIO stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 0 | |
| 15,000,000 | |
| 15,900,000 | |
| 14,900,000 | |
| -15,300,000 | |
| 15,300,000 | |
| 16,400,000 | |
| 15,600,000 | |
| 15,000,000 | |
| 15,300,000 | |
| 16,200,000 | |
| 15,900,000 | |
| 12,600,000 | |
| 16,600,000 | |
| 18,100,000 | |
| 15,700,000 | |
| 13,600,000 | |
| 13,500,000 | |
| 15,000,000 | |
| 13,100,000 | |
| 11,400,000 | |
| 11,700,000 | |
| 12,300,000 | |
| 10,800,000 | |
| 8,800,000 | |
| 9,700,000 | |
| 10,200,000 | |
| 9,100,000 | |
| 7,800,000 | |
| 8,500,000 | |
| 8,600,000 | |
| 7,100,000 | |
| 6,200,000 | |
| 5,900,000 | |
| 6,786,000 | |
| 6,000,000 | |
| 5,200,000 | |
| 5,400,000 | |
| 5,382,000 | |
| 4,911,000 | |
| 4,762,000 | |
| 4,645,000 | |
| 4,691,000 | |
| 4,004,000 | |
| 4,234,000 | |
| 4,071,000 | |
| 4,186,000 | |
| 3,332,000 | |
| 3,681,000 | |
| 3,701,000 | |
| 3,806,000 | |
| 3,113,000 | |
| 3,299,000 | |
| 3,482,000 | |
| 3,952,000 | |
| 2,922,000 | |
| 3,190,000 | |
| 3,136,000 | |
| 2,884,000 | |
| 2,512,000 | |
| 2,521,000 | |
| 2,783,000 | |
| 2,843,000 | |
| 2,533,000 | |
| 2,538,000 | |
| 2,286,000 | |
| 0 | |
| 2,553,000 | |
| 2,070,000 | |
| 2,047,000 | |
| 0 | |
| 2,157,000 | |
| 1,533,000 | |
| 1,586,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |